Category Filter
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HelpScript Program
- Hemophilia Drugs
- Medical Oncology Regimen Program
- Medical Policies
- Pharmacy
- Pre-Service Review (Precertification and Predetermination)
- Pre-Service Review (Precertification/Predetermination)
- Pre-Service Review (Predetermination/Precertification)
- Provider-Administered Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
Asset Publisher
Content with Policies & Guidelines Final Self-Administered Drug Policies .
Akynzeo, Anzemet, Emend, granisetron, ondansetron ODT, Sancuso, Varubi, Zofran, Zofran ODT, Zuplenz
Atacand, Atacand HCT, Avapro, Avalide, Azor, Benicar, Benicar HCT, Cozaar, Diovan, Diovan HCT, Edarbi, Edarbyclor, Eprosartan, Exforge, Exforge HCT, Hyzaar, Micardis, Micardis HCT, Tribenzor...
Abilify, Abilify Mycite, Caplyta, Clozapine ODT, Cobenfy Fanapt, Geodon, Invega ER, Latuda, Lybalvi, Rexulti, Risperdal, Risperdal M-Tab, Risperidone Orally Disintegrating Tab, Saphris, Secuado,...
Amitiza, Ibsrela, Linzess, Lubiprostone, Motegrity, Movantik, Relistor, Symproic, Trulance, Zelnorm
Genotropin, Humatrope, Ngenla, Norditropin, Nutropin AQ, Omnitrope, Saizen, Serostim, Skytrofa, Sogroya, Zomacton, Zorbtive